296 results on '"Mariani B"'
Search Results
252. [Deficiency diet and experimental infection with atypical mycobacteria in the guinea pig].
253. [Effect of isonicotinic acid hydrazide on arterial pressure in cat].
254. [Biochemical and functional modifications in surgical interventions in tuberculosis].
255. [Effects of cortisone on experimental tuberculosis; its similarity to bile salts].
256. [Bronchial papilloma and papillomatosis. Anatomoclinical contribution].
257. [Pharmacological stimulation of the vegetative nervous system and biochemical and immunological changes in tuberculosis].
258. [ON THE THERAPEUTIC EFFECTS AND SIDE-EFFECTS OF MORPHAZINAMIDE IN THE CURE OF TUBERCULOSIS. (SUMMARY)].
259. THE ANTITUBERCULOSIS ISONIAZID CHEMOPROPHYLAXIS ON HUMANS AND CATTLE.
260. [Latest observations in man experimental animals on hepatic function, gastric secretion and blood uric acid in the course of therapy with morphazinamide].
261. [New therapeutic possibilities of amminosidin in pneumology (bacteriologic, physiopathologic and clinical observations)].
262. [Observations on various biological characteristics of the so-called atypical mycobacteria].
263. [THE ANTITUBERCULOSIS CHEMOPROPHYLAXIS BY ISONIAZID IN HUMANS AND CATTLE].
264. Diffuse endoalveolar pulmonary microlithiasis.
265. [Contribution to the treatment of hepatopathic manifestations in the course of tuberculosis with combined vitamin B12, folic acid, vitamin C and vitamin PP].
266. Practical value of the search for specific defense proteases for the diagnosis of tuberculosis.
267. [Prospects of the use of the anti-tuberculosis vaccination with SDV (Salvioli's diffusing vaccine) in the current epidemiologic phase of tuberculosis].
268. [Jaundice due to secondary amyloidosis].
269. [Blood calcium increase after administration of calcium ethylenediamine tetraacetate].
270. [Current research on intra-alveolar pulmonary microlithiasis (Malpighi's disease). Proposals for an anatomo-clinical classification].
271. [Etiology and pathogenesis of diffuse pulmonary calcifications].
272. [The clinical syndrome of isolated miliary tuberculosis of the liver; acute portogenous miliary].
273. [Appearance of a reducing property in the urine of tuberculotics during PAS therapy].
274. [Pharmacological stimulation of the autonomic nervous system and biochemical and immunological modifications in tuberculosis].
275. [Experimental infection with atypical mycobacteria in the mouse. Influence of periodic fasting and deficiency of proteins and salt].
276. [Lipidosis of the lung].
277. [The identification of the reducing substance in the urine following PAS administration].
278. [Use of morphazinamide in therapy of tuberculosis in association with other antitubercular drugs and with intravenous, intrapleural and intraperitoneal administration].
279. [Present applications of tuberculin desensitizing therapy].
280. [Experimental and clinico-therapeutic research with terizidone in tuberculosis].
281. [Laboratory data on the first results of isonicotinic acid hydrazide in the therapy of tuberculosis].
282. [Determination of choline and its metabolites in urine and significance of their urinary elimination].
283. [Biochemical factors and the origin, course and cure of tuberculosis and mycobacterium infections].
284. [The lung as a metabolic organ and dysmetabolic pathology of the lung].
285. [CHANGES IN HEPATIC FUNCTION DURING ANTIBACTERIAL CHEMOTHERAPY].
286. [Eosinophilic leukemia (considerations on a case)].
287. [Laboratory data on several tubercular subjects during isonicotinic acid hydrazide therapy].
288. [The liver and tuberculosis].
289. [Pathogenesis of hypovitaminosis A in tuberculosis; the effect of lipotropic substances on the vitamin A and carotene blood levels in tuberculosis].
290. [Morphological observations, with special regard to electron microscopy, on various so-called atypical mycobacteria].
291. [Effects of pyrazinamide and cycloserine therapy of tuberculosis on clinical and functional liver reactions and on certain biological tests].
292. [Administration by slow phleboclysis of isoniazid and para-aminosalicylic acid in the treatment of tuberculosis. Therapeutic effects and blood levels of the drug].
293. [Various clinical and neoplastic pulmonary alveolar syndromes. Primary and secondary (non metastatic) forms].
294. [Biochemical indices and tests of hepatic, renal and adrenal function in the surgery of pulmonary tuberculosis].
295. [Pharmacological stimulation of the autonomic nervous system and biochemical and immunological changes in tuberculosis].
296. [Bacteriologic and clinical observations on the gentamicin effect in pneumology].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.